Jarno Hoekman

Citado por

	Total	Desde 2015
Citas	2229	1544
Índice h	20	18
Índice i10	30	27

340

170

255

20082009201020112012201320142015201620172018201920207 31 49 82 70 197 208 195 209 239 262 327 305

Coautores

Koen FrenkenFull Professor in Innovation Studies, Utrecht UniversityDirección de correo verificada de uu.nl
Marie L De BruinAssistant Professor, Utrecht UniversityDirección de correo verificada de uu.nl
Dick de ZeeuwProfessor Clinical Pharmacology, University of Groningen, University Medical Center Groningen, Groningen, The NetherlandsDirección de correo verificada de umcg.nl
Hiddo Lambers HeerspinkUniversity of GroningenDirección de correo verificada de umcg.nl
Robert J.W. TijssenProfessor of Science and Innovation Studies, Leiden University; Stellenbosch UniversityDirección de correo verificada de cwts.leidenuniv.nl
Wouter BoonInnovation Studies Groups, Utrecht UniversityDirección de correo verificada de uu.nl
hans c. ebbersUtrecht UniversityDirección de correo verificada de uu.nl
Pieter StolkUtrecht UniversityDirección de correo verificada de uu.nl
Ismael RafolsCentre for Science and Technology Studies (CWTS), University of LeidenDirección de correo verificada de cwts.leidenuniv.nl
Paul NightingaleSussexDirección de correo verificada de sussex.ac.uk
Antonio Perianes-Rodríguez (ORCID I...Universidad Carlos III de Madrid, UC3MDirección de correo verificada de uc3m.es
Michael M HopkinsProfessor of Innovation Management, SPRU, University of Sussex Business SchoolDirección de correo verificada de sussex.ac.uk
Josh SiepelSenior Lecturer, SPRU, University of SussexDirección de correo verificada de sussex.ac.uk
Diederick E. GrobbeeProfessor of Clinical Epidemiology, University Medical Center UtrechtDirección de correo verificada de umcutrecht.nl
Eijkemans, MJCProfessor of biostatisticsDirección de correo verificada de umcutrecht.nl
Thomas ScherngellResearcher, AIT Austrian Insitute of TechnologyDirección de correo verificada de ait.ac.at
Bauke SchievinkUniversity Medical Center GroningenDirección de correo verificada de umcg.nl
Gaston HeimeriksInnovation Studies, Utrecht UniversityDirección de correo verificada de uu.nl
remuzzi g*Istituto di Ricerche Farmacologiche Mario Negri Dirección de correo verificada de marionegri.it
Vlado PerkovicDean of Medicine, University of New South Wales; Professorial Fellow, The George InstituteDirección de correo verificada de george.org.au

Jarno Hoekman

Innovation Studies Group, Utrecht University

Dirección de correo verificada de uu.nl - Página principal

Innovation Regulatory Science Technology Assessment Scientometrics STS


Título Ordenar por citas Ordenar por año Ordenar por título	Citado por Citado por	Año
Research collaboration at a distance: Changing spatial patterns of scientific collaboration within Europe J Hoekman, K Frenken, RJW Tijssen Research Policy 39 (5), 662-673, 2010	516	2010
The geography of collaborative knowledge production in Europe J Hoekman, K Frenken, F Van Oort The Annals of Regional Science 43 (3), 721-738, 2009	404	2009
Spatial scientometrics: Towards a cumulative research program K Frenken, S Hardeman, J Hoekman Journal of informetrics 3 (3), 222-232, 2009	269	2009
Drug-induced reduction in albuminuria is associated with subsequent renoprotection: a meta-analysis HJL Heerspink, TF Kröpelin, J Hoekman, D De Zeeuw Journal of the American Society of Nephrology 26 (8), 2055-2064, 2015	139	2015
Big Pharma, Little Science? A bibliometric perspective on big pharma’s R&D decline I Rafols, M Hopkins, J Hoekman, P Nightingale, A Perianes-Rodriguez, ... Technological Forecasting and Social Change, 2012	113	2012
Acquisition of European research funds and its effect on international scientific collaboration J Hoekman, T Scherngell, K Frenken, R Tijssen Journal of economic geography 13 (1), 23-52, 2013	93	2013
Adverse drug reaction reporting in Africa and a comparison of individual case safety report characteristics between Africa and the rest of the world: analyses of spontaneous … HH Ampadu, J Hoekman, ML de Bruin, SN Pal, S Olsson, D Sartori, ... Drug Safety 39 (4), 335-345, 2016	78	2016
Death of distance in science? A gravity approach to research collaboration K Frenken, J Hoekman, S Kok, R Ponds, F van Oort, J van Vliet Innovation networks, 43-57, 2009	53	2009
Use of the conditional marketing authorization pathway for oncology medicines in Europe J Hoekman, WPC Boon, JC Bouvy, HC Ebbers, JP de Jong, ML De Bruin Clinical Pharmacology & Therapeutics 98 (5), 534-541, 2015	42	2015
Convergence in an enlarged Europe: the role of network cities K Frenken, J Hoekman Tijdschrift voor economische en sociale geografie 97 (3), 321-326, 2006	40	2006
The Geographical Distribution of Leadership in Globalized Clinical Trials J Hoekman, K Frenken, D de Zeeuw, HL Heerspink PLOS ONE 7 (10), e45984, 2012	36	2012
Collaboration networks as carriers of knowledge spillovers J Hoekman, K Frenken, F Van Oort KITeS Working Papers 222, 2008	33	2008
What drives university research performance? An analysis using the CWTS Leiden Ranking data K Frenken, GJ Heimeriks, J Hoekman Journal of informetrics 11 (3), 859-872, 2017	31	2017
Characteristics and follow‐up of postmarketing studies of conditionally authorized medicines in the EU J Hoekman, TT Klamer, AK Mantel‐Teeuwisse, HGM Leufkens, ... British journal of clinical pharmacology 82 (1), 213-226, 2016	31	2016
Spatial scientometrics and scholarly impact: A review of recent studies, tools, and methods K Frenken, J Hoekman Measuring scholarly impact, 127-146, 2014	26	2014
Towards a European research area K Frenken, J Hoekman, FG van Oort Achtergronden 3, 2007	24	2007
Prediction of the effect of atrasentan on renal and heart failure outcomes based on short-term changes in multiple risk markers B Schievink, D De Zeeuw, PA Smink, D Andress, JJ Brennan, B Coll, ... European Journal of Preventive Cardiology 23 (7), 758-768, 2016	22	2016
The importance of short‐term off‐target effects in estimating the long‐term renal and cardiovascular protection of angiotensin receptor blockers PA Smink, Y Miao, MJC Eijkemans, SJL Bakker, I Raz, HH Parving, ... Clinical Pharmacology & Therapeutics 95 (2), 208-215, 2014	22	2014
Challenges in advanced therapy medicinal product development: a survey among companies in Europe RMT ten Ham, J Hoekman, AM Hövels, AW Broekmans, HGM Leufkens, ... Molecular Therapy-Methods & Clinical Development 11, 121-130, 2018	20	2018
Predictors of congestive heart failure after treatment with an endothelin receptor antagonist J Hoekman, HJL Heerspink, G Viberti, D Green, JFE Mann, D de Zeeuw Clinical Journal of the American Society of Nephrology 9 (3), 490-498, 2014	20	2014

El sistema no puede realizar la operación en estos momentos. Inténtalo de nuevo más tarde.

Artículos 1–20

Citas por año

Citas duplicadas

Citas combinadas

Añadir coautoresCoautores

Subir PDF

Seguir a este autor

Citado por

Coautores